X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3493) 3493
Publication (273) 273
Book Review (73) 73
Newsletter (60) 60
Magazine Article (21) 21
Book Chapter (4) 4
Dissertation (4) 4
Book / eBook (2) 2
Conference Proceeding (2) 2
Government Document (2) 2
Data Set (1) 1
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
celecoxib (3236) 3236
humans (2514) 2514
index medicus (1450) 1450
male (1400) 1400
sulfonamides - therapeutic use (1335) 1335
female (1315) 1315
animals (915) 915
middle aged (895) 895
pyrazoles - therapeutic use (892) 892
anti-inflammatory agents, non-steroidal - therapeutic use (844) 844
nonsteroidal antiinflammatory drugs (804) 804
aged (748) 748
cyclooxygenase inhibitors - therapeutic use (748) 748
pharmacology & pharmacy (718) 718
adult (676) 676
cyclooxygenase 2 inhibitors - therapeutic use (665) 665
oncology (615) 615
cox-2 inhibitors (600) 600
anti-inflammatory agents, non-steroidal - adverse effects (547) 547
pyrazoles (547) 547
treatment outcome (517) 517
sulfonamides - adverse effects (516) 516
cyclooxygenase-2 (475) 475
rheumatoid-arthritis (465) 465
rofecoxib (439) 439
sulfonamides - pharmacology (429) 429
osteoarthritis (427) 427
cancer (419) 419
nonsteroidal anti-inflammatory drugs (402) 402
mice (399) 399
cyclooxygenase 2 (382) 382
sulfonamides - administration & dosage (374) 374
rats (354) 354
cyclooxygenase 2 inhibitors (351) 351
double-blind method (338) 338
expression (335) 335
cyclooxygenase inhibitors - adverse effects (332) 332
pyrazoles - pharmacology (332) 332
inflammation (323) 323
risk (317) 317
apoptosis (302) 302
drug therapy (302) 302
prevention (302) 302
membrane proteins (301) 301
cox-2 (300) 300
risk factors (299) 299
care and treatment (297) 297
pyrazoles - administration & dosage (297) 297
pyrazoles - adverse effects (296) 296
research (293) 293
aged, 80 and over (288) 288
double-blind (287) 287
cyclooxygenase 2 - metabolism (280) 280
cyclooxygenase 2 inhibitors - pharmacology (278) 278
angiogenesis inhibitors (277) 277
lactones - therapeutic use (269) 269
medicine, general & internal (264) 264
gastrointestinal toxicity (257) 257
cyclooxygenase 2 inhibitors - adverse effects (247) 247
osteoarthritis - drug therapy (246) 246
analysis (240) 240
dose-response relationship, drug (240) 240
drug therapy, combination (230) 230
aspirin (224) 224
cyclooxygenase-2 inhibitor (224) 224
antineoplastic combined chemotherapy protocols - therapeutic use (214) 214
cell line, tumor (213) 213
isoenzymes - antagonists & inhibitors (213) 213
pain (212) 212
sulfones (210) 210
arthritis (209) 209
clinical trials (206) 206
rheumatology (206) 206
cyclooxygenase inhibitors - pharmacology (201) 201
celecoxib - therapeutic use (196) 196
naproxen (195) 195
nsaids (195) 195
chemoprevention (190) 190
drugs (189) 189
health aspects (188) 188
chemotherapy (184) 184
cyclooxygenase 2 inhibitors - administration & dosage (184) 184
lactones - adverse effects (184) 184
medicine & public health (182) 182
anti-inflammatory agents, non-steroidal - pharmacology (180) 180
disease models, animal (177) 177
arthritis, rheumatoid - drug therapy (173) 173
antineoplastic agents - therapeutic use (171) 171
randomized controlled trials as topic (171) 171
gastroenterology & hepatology (170) 170
surgery (168) 168
time factors (168) 168
anti-inflammatory agents, non-steroidal - administration & dosage (167) 167
pain measurement (167) 167
adolescent (166) 166
medicine, research & experimental (165) 165
dosage and administration (164) 164
efficacy (163) 163
medicine (163) 163
article (161) 161
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3407) 3407
German (43) 43
French (32) 32
Chinese (28) 28
Spanish (20) 20
Russian (16) 16
Japanese (13) 13
Italian (7) 7
Polish (3) 3
Swedish (3) 3
Croatian (2) 2
Persian (2) 2
Czech (1) 1
Danish (1) 1
Finnish (1) 1
Hungarian (1) 1
Korean (1) 1
Lithuanian (1) 1
Serbian (1) 1
Turkish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Expert Opinion on Drug Metabolism & Toxicology, ISSN 1742-5255, 04/2016, Volume 12, Issue 4, pp. 423 - 431
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 02/2018, Volume 2018, Issue 2, p. CD004121
Background This is an updated version of the original Cochrane review published in 2014, Issue 4. Cervical intraepithelial neoplasia (CIN) precedes the... 
COX-2 | Sulfones [administration & dosage; therapeutic use] | Humans | Sulfonamides [administration & dosage; therapeutic use] | COLON-CANCER | MEDICINE, GENERAL & INTERNAL | PHASE-II TRIAL | CHEMOPREVENTIVE ACTIVITY | TRANSITIONAL-CELL CARCINOMA | Pyrazoles [administration & dosage; therapeutic use] | Female | Lactones [administration & dosage; therapeutic use] | INHIBITOR | UP-REGULATION | Uterine Cervical Neoplasms [drug therapy] | Administration, Oral | Induction Chemotherapy [methods] | Celecoxib | Disease Progression | Randomized Controlled Trials as Topic | DOUBLE-BLIND | Cyclooxygenase 2 Inhibitors [administration & dosage; therapeutic use] | CYCLOOXYGENASE-2 EXPRESSION | Anti-Inflammatory Agents, Non-Steroidal [administration & dosage; therapeutic use] | Cervical Intraepithelial Neoplasia [drug therapy] | Sulfones - therapeutic use | Cervical Intraepithelial Neoplasia - pathology | Cyclooxygenase 2 Inhibitors - administration & dosage | Induction Chemotherapy - methods | Cervical Intraepithelial Neoplasia - drug therapy | Uterine Cervical Neoplasms - drug therapy | Uterine Cervical Neoplasms - pathology | Celecoxib - therapeutic use | Lactones - therapeutic use | Placebos - therapeutic use | Sulfonamides - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Lactones - administration & dosage | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Cyclooxygenase 2 Inhibitors - therapeutic use | Adult | Sulfonamides - administration & dosage | Sulfones - administration & dosage
Journal Article
Journal Article
New England Journal of Medicine, ISSN 0028-4793, 12/2016, Volume 375, Issue 26, pp. 2519 - 2529
BACKGROUND The cardiovascular safety of celecoxib, as compared with nonselective nonsteroidal anti-inflammatory drugs (NSAIDs), remains uncertain. METHODS... 
MEDICINE, GENERAL & INTERNAL | PAIN | METAANALYSIS | OSTEOARTHRITIS | CLINICAL-TRIAL | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | Celecoxib - adverse effects | Naproxen - adverse effects | Ibuprofen - therapeutic use | Humans | Middle Aged | Male | Risk | Celecoxib - therapeutic use | Naproxen - therapeutic use | Cyclooxygenase 2 Inhibitors - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Arthritis - drug therapy | Cyclooxygenase 2 Inhibitors - therapeutic use | Intention to Treat Analysis | Kidney Diseases - chemically induced | Cardiovascular Diseases - mortality | Female | Aged | Cardiovascular Diseases - chemically induced | Ibuprofen - adverse effects | Gastrointestinal Diseases - chemically induced | Care and treatment | Safety and security measures | Naproxen | Ibuprofen | Dosage and administration | Arthritis | Celecoxib | Diagnosis | Cardiovascular diseases | Risk factors | Cardiovascular disease | Side effects | Nonsteroidal anti-inflammatory drugs | Pain management | Myocardial infarction | Fees & charges | Hemorrhage | Pain | Motivation | Analgesics | Safety | Drug dosages | Cerebral infarction | Statistical analysis | Anemia | Committees | FDA approval | Patients | Manuscripts | Rheumatoid arthritis | Collaboration | Osteoarthritis | Pharmaceuticals
Journal Article
The Journal of Bone & Joint Surgery, ISSN 0021-9355, 02/2013, Volume 95, Issue 4, pp. 291 - 296
BACKGROUND:Appropriate pain management affects outcome after hip fracture surgery. Although multimodal pain management is commonly used for pain control for... 
KNEE | SURGERY | DEMENTIA | TOTAL JOINT ARTHROPLASTY | DELIRIUM | HOSPITAL STAY | LOCAL INFILTRATION ANALGESIA | ELDERLY PATIENTS | ORTHOPEDICS | PUMP | CONSUMPTION | POSTOPERATIVE PAIN | Fentanyl - administration & dosage | Single-Blind Method | Hip Fractures - surgery | Pyrazoles - therapeutic use | Prospective Studies | Fentanyl - therapeutic use | Humans | Male | Adrenergic alpha-Agonists - therapeutic use | Arthroplasty, Replacement, Hip - methods | Adrenergic alpha-Agonists - administration & dosage | Epinephrine - therapeutic use | Cyclooxygenase 2 Inhibitors - therapeutic use | Statistics, Nonparametric | Aged, 80 and over | Anesthetics, Local - therapeutic use | Anesthetics, Local - administration & dosage | Oxycodone - therapeutic use | Oxycodone - administration & dosage | Cyclooxygenase 2 Inhibitors - administration & dosage | Pain Management - methods | Analgesics, Opioid - therapeutic use | Anti-Bacterial Agents - administration & dosage | Morphine - administration & dosage | Sulfonamides - administration & dosage | Ketorolac - therapeutic use | Pain, Postoperative - drug therapy | Epinephrine - administration & dosage | Patient Satisfaction | Anti-Bacterial Agents - therapeutic use | Cefmetazole - therapeutic use | Female | Drug Therapy, Combination | Analgesia, Patient-Controlled | Treatment Outcome | Amides - therapeutic use | Celecoxib | Chi-Square Distribution | Pyrazoles - administration & dosage | Sulfonamides - therapeutic use | Analgesics, Opioid - administration & dosage | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Injections, Intra-Articular | Aged | Ketorolac - administration & dosage | Pain Measurement | Amides - administration & dosage | Morphine - therapeutic use | Cefmetazole - administration & dosage
Journal Article
International Journal of Cancer, ISSN 0020-7136, 09/2008, Volume 123, Issue 5, pp. 983 - 990
Statins and nonsteroidal antiinflammatory drugs (NSAIDs) are commonly prescribed for lowering cholesterol and antiinflammation, respectively. Recently, their... 
cancer chemoprevention | statins | NSAIDs | Cancer chemoprevention | Statins | CELECOXIB INDUCES APOPTOSIS | HUMAN LUNG-CANCER | SELECTIVE COX-2 INHIBITORS | PREVENT COLORECTAL ADENOMAS | COLON-CANCER | ONCOLOGY | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | CHOLESTEROL-LOWERING DRUGS | FAMILIAL ADENOMATOUS POLYPOSIS | NF-KAPPA-B | ENDOTHELIAL GROWTH-FACTOR | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Simvastatin - therapeutic use | Meta-Analysis as Topic | Pyrazoles - therapeutic use | Heptanoic Acids - therapeutic use | Humans | Neoplasms - prevention & control | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Fatty Acids, Monounsaturated - therapeutic use | Anticarcinogenic Agents - administration & dosage | Aspirin - therapeutic use | Drug Therapy, Combination | Pyrroles - therapeutic use | Anticarcinogenic Agents - pharmacology | Pravastatin - therapeutic use | Anticarcinogenic Agents - therapeutic use | Pyridines - therapeutic use | Lovastatin - therapeutic use | Drug Administration Schedule | Colorectal Neoplasms - prevention & control | Celecoxib | Sulindac - therapeutic use | Evidence-Based Medicine | Randomized Controlled Trials as Topic | Drug Synergism | Atorvastatin Calcium | Animals | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Sulfonamides - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Indoles - therapeutic use | Index Medicus
Journal Article